Proctor JR, Gartner EM, Gray TE, Davies RH, et al. Population pharmacokinetics of zanidatamab, an anti-HER2 biparatopic antibody, in patients with advanced or metastatic cancer. Cancer Chemother Pharmacol 2022;90:399-408.
PMID: 36102999